Cytomegalovirus (CMV) is a member of the herpesvirus family and is widespread, infecting people of all ages worldwide. Transmission commonly occurs through bodily fluids, including saliva, urine, blood, and breast milk. In healthy individuals, CMV infections are often asymptomatic or cause mild flu-like symptoms. However, CMV poses a greater risk to individuals with weakened immune systems, such as transplant recipients, HIV/AIDS patients, and newborns. Congenital CMV, transmitted from an infected mother to her baby during pregnancy, can result in developmental issues and long-term health complications. CMV establishes lifelong latency after primary infection, and reactivation can occur during periods of immunosuppression. Diagnosis involves various laboratory tests, including polymerase chain reaction (PCR) and serological assays. Antiviral medications are available for severe or symptomatic cases, but no vaccine is currently approved for general use. Prevention strategies include practicing good hygiene, especially for pregnant women, and implementing infection control measures in healthcare settings to reduce the risk of transmission.
Khursheed Nadeem Anwer
IMUNON, United States
Ping Xie
Rutgers University, United States
Regina Au
BioMarketing Insight, United States
Madhu Khanna
University of Delhi, India
Ahmed Abdulazeez
BHRUT Trust, United KingdomSubmit your abstract Today
Title : A promising novel approach to DNA vaccines
Khursheed Nadeem Anwer, IMUNON, United States
Title : Nanoscopic SubATVax™ adjuvanted vaccines against influenza A types H3N2, H1N1 and influenza type B for subcutaneous administration
David Craig Wright, D4 Labs, LLC, United States
Title : The importance of post-marketing surveillance and real-world data for a product to be successful
Regina Au, BioMarketing Insight, United States
Title : Prophylactic and molecular approaches for mitigating human influenza A viruses: i. Evaluating influenza vaccine effectiveness in the older population ii. Down-regulation of influenza virus genes with novel sirna-chimeric-ribozyme constructs
Madhu Khanna, University of Delhi, India
Title : Commensal bacteria drive B-cell lymphomagenesis in the setting of innate immunodeficiency
Ping Xie, Rutgers University, United States
Title : The role of immunity in the pathogenesis of SARS-COV-2 and in the protection generated by COVID-19 in different age groups
Ahmed Abdulazeez, BHRUT Trust, United Kingdom
Title : Establishing a platform method for physical appearance assessment of new parenteral pharmaceuticals
Ying Wan, Merck & Co., United States
Title : Evaluating the immunogenic impact of process impurities in mRNA vaccine production: Establishing integrated control strategies and specifications
Jesse Kuiper, Merck Research Laboratories, United States
Title : New biomarkers in leishmania major vaccine development
Negar Seyed, Pasteur Institute of Iran, Iran (Islamic Republic of)
Title : Advances in vaccines: Revolutionizing disease prevention
Delia Teresa Sponza, Dokuz Eylul University, Turkey